SLT 0.00% 0.7¢ select exploration limited

interesting comparison

  1. 5,609 Posts.
    This was in an article on UNI. I think SLT is similar in that it has products ready to go and wont spend years in labs, interesting. Perhaps the market likes this company for a reason? These sorts of stories are easier to value when the deals get done and the cash starts to flow quicker than other companies.

    Unitract's unique offering and its relatively quick track to market – compared to biotech companies which must take years to trial drugs – has made it a favourite with investors, raising $24 million in nine months and attracting several large institutions to its register
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.